Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects
about
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsAssociation of Escherichia coli O157:H7 tir polymorphisms with human infection.Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndromeCharacterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors.Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2.A reverse-sandwich enzyme-linked immunosorbent assay for verocytotoxin 1 and 2 antibodies in human and bovine sera.Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicityRole of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.Heterologous antigen expression in Vibrio cholerae vector strainsSerum antibody responses of cattle following experimental infection with Escherichia coli O157:H7Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strainsVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro.A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups
P2860
Q24550740-E18565DD-5B18-45EE-A165-CEE3F3C90651Q33295079-50E337B9-4AEF-4D94-BD49-F505AE9DE36FQ33337454-9EC0E6C5-FED9-4013-9BE8-E399F86DCB13Q33342197-28EB6A8F-1E93-47B1-9658-93A1012F4698Q33357487-42A8DB53-E3A9-4478-8655-348DFE215E9EQ33403923-C3A105EA-1B91-47D7-A447-34CD178A94E4Q33412829-93572F29-9D15-49A1-99F0-75AA89B92718Q33419153-1A1A3ED1-FADC-4D2E-97D3-9AE65F967C3CQ33498518-0317AC56-1D11-46FF-87EF-A8AF91184CCEQ33598843-D47B478D-59EA-4FC6-AC5D-24C8AB9AB6F7Q33877305-C6468348-CAD1-4118-9F11-18AF539B09CAQ33997875-163F561A-4A37-4094-B371-94BEAEB6E068Q34002364-EDF00726-4F42-4319-B312-48E82673346CQ34119320-BE05E05C-310E-4862-914A-E9EE38639261Q34596249-61DCE6B4-5E0A-4DBA-BDC8-5178BFF78750Q35423953-9F299797-BE1A-414D-AA03-B7DB257A3B9FQ35493730-CD6D926B-FECF-4EEB-B618-3BA65D3A43BAQ35548775-2FA8A73B-8DB0-4AF3-92B7-2DF08D43EC15Q35887055-232D171E-C1C5-482D-9513-FBC98F5BC132Q35923378-5A9307EA-4955-4BDC-B22D-D04C04BFCA20Q39432827-21E9A5CE-C49D-49DB-BA78-62C851F9212FQ39610465-4A565BC2-27E5-4E14-AFBD-378BF4120132Q42370652-0D525E1C-EA02-4A38-9679-2C683966FFE1
P2860
Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Humoral immune responses to Sh ...... patients and healthy subjects
@ast
Humoral immune responses to Sh ...... patients and healthy subjects
@en
type
label
Humoral immune responses to Sh ...... patients and healthy subjects
@ast
Humoral immune responses to Sh ...... patients and healthy subjects
@en
prefLabel
Humoral immune responses to Sh ...... patients and healthy subjects
@ast
Humoral immune responses to Sh ...... patients and healthy subjects
@en
P2860
P1476
Humoral immune responses to Sh ...... patients and healthy subjects
@en
P2093
Greatorex JS
P2860
P304
P407
P577
1994-05-01T00:00:00Z